Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease
Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease have?
Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease has 9 citations in the OpenAlex counts ScholarIQ stores.
When was Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease published?
Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease has 2003 year in the ScholarIQ index.
What is the open-access status of Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease?
Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease has closed oa status in the ScholarIQ index.
What is the DOI of Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease?
The DOI for Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease is on the source record.
What is the PMID of Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease?
The PMID for Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease is on the source record.
What is the OpenAlex record for Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease?
The OpenAlex for Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease is on the source record.